Sign In
Buy STIM
$1.20
-0.0300 (-2.44%)
At Close: Jun 22, 2026
New Strong Sell Stocks for August 31st
10:40am, Tuesday, 31'st Aug 2021
AMWD, CYTK, STIM, OLLI, and THMO have been added to the Zacks Rank #5 (Strong Sell) List on August 31, 2021.
New Strong Sell Stocks for August 25th
11:34am, Wednesday, 25'th Aug 2021
BEEM, CHRS, KMDA, STIM and PHUN have been added to the Zacks Rank #5 (Strong Sell) List on August 25, 2021
Neuronetics Launches New Website to Meet Patient Demand for Depression Resources
08:31am, Tuesday, 17'th Aug 2021
New site enhances the user experience and offers expanded content for depression sufferers New site enhances the user experience and offers expanded content for depression sufferers
Neuronetics, Inc. (STIM) CEO Keith Sullivan on Q2 2021 Results - Earnings Call Transcript
10:43am, Sunday, 08'th Aug 2021
Neuronetics, Inc. (STIM) CEO Keith Sullivan on Q2 2021 Results - Earnings Call Transcript
New Strong Sell Stocks for August 6th
10:44am, Friday, 06'th Aug 2021
AVA, IDN, KOPN, PRIM, and STIM have been added to the Zacks Rank #5 (Strong Sell) List on August 6, 2021.
Neuronetics Announces Appointment of Megan Rosengarten to its Board of Directors
04:30pm, Thursday, 05'th Aug 2021
MALVERN, Pa., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve t
Neuronetics Stock Plunges As Q2 Earnings Miss Expectations; Underwhelming Q3 Revenue Outlook
11:53am, Tuesday, 03'rd Aug 2021
Neuronetics Inc (NASDAQ: STIM) reported Q2 EPS loss of $(0.29) lower than $(0.41) posted a year ago, but missing the consensus of $(0.24). Revenue of $14.2 million, missed the consensus of $14.72 m
Neuronetics Reports Second Quarter 2021 Financial and Operating Results
07:30am, Tuesday, 03'rd Aug 2021
MALVERN, Pa., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve th
7 Stocks to Buy if You Think Alternative Therapies Are the Future
12:52pm, Monday, 02'nd Aug 2021
Here are seven stocks to buy if you're optimistic about the potential for alternative therapies to become mainstream treatments. The post 7 Stocks to Buy if You Think Alternative Therapies Are the Fut
Neuronetics to Report Second Quarter 2021 Financial and Operating Results and Host Conference Call
08:30am, Tuesday, 20'th Jul 2021
MALVERN, Pa., July 20, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve th
Neuronetics Launches Enhanced Digital Resource Center for NeuroStar Providers
08:15am, Wednesday, 14'th Jul 2021
The redesigned My NeuroStar Resource Center provides user-friendly tools to help practices expand awareness of NeuroStar® Advanced Therapy for Mental Health The redesigned My NeuroStar Resource C
Neuronetics Set to Join Russell 2000® Index
05:29pm, Wednesday, 23'rd Jun 2021
MALVERN, Pa., June 23, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve th
Neuronetics, Inc (NVO) CEO Keith Sullivan on Q1 2021 Results - Earnings Call Transcript
10:25am, Thursday, 06'th May 2021
Neuronetics, Inc (NVO) CEO Keith Sullivan on Q1 2021 Results - Earnings Call Transcript
Neuronetics (STIM) Soars 39.2%: Is Further Upside Left in the Stock?
03:01am, Thursday, 06'th May 2021
Neuronetics (STIM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the
Why Neuronetics Blasted 39% Higher Today
05:41pm, Tuesday, 04'th May 2021
The company is experiencing a strong rise in demand.
